SERB

Location

ILE DE FRANCE

Founded

1951-07-25

Risk Signals

32 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about SERB

Live alerts from global media, monitored by Business Radar

SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company's growth

2024-05-30 (globenewswire.com)

SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company's growth

Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its...

Read more

Never miss a headline about SERB

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages